News summary

Paper-based 3D cell culture platform for cholesterol efflux capacity assay

Source: Nature - Biotechnology • Published: 13 Oct 2026, 00:00

Summarized by Masters of Longevity from Nature - Biotechnology.

A methods-focused article presenting a paper-based 3D cell culture platform for measuring cholesterol efflux capacity, useful for researchers seeking alternative assay formats.

Paper-based 3D cell culture platform for cholesterol efflux capacity assay
Key Takeaways
  • Foam cell formation was induced by PMA-driven macrophage differentiation followed by BODIPY-cholesterol loading and was confirmed by microscopy and CD marker imaging.
  • Cholesterol efflux capacity measured from the paper-based platform correlates strongly with results from a commercial cell-based CEC assay across volunteer samples.
Read the full article at Nature - Biotechnology ↗

Continue exploring

Recommended MoL Picks

MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?MoL PickThe Next Obesity-Drug Race Is About What Weight You LoseRegeneron’s myostatin and activin A antibodies point to a sharper question for the GLP-1 era: not whether people can lose more weight, but whether medicine can preserve the tissue that makes weight loss healthier.